lab-on-a-particle CRISPR detection

Accurate and early detection of diseases is key to improving healthcare, but current diagnostic tests often lack precision, leading to delays, false alarms, and higher healthcare costs. Our innovative solution uses advanced nanotechnology and CRISPR—a cutting-edge molecular tool—to create ultra-sensitive tests that detect tiny traces of disease markers at very early stages. These tests are […]

Glow-in-the-dark molecular diagnostics

Quantitative PCR (qPCR) is a reliable and sensitive method for detecting DNA and RNA, and is widely considered the gold standard. However, qPCR needs costly equipment, skilled technicians, and specialized labs, which means tests can take several hours. The COVID-19 pandemic showed that while qPCR is effective for detecting infectious diseases, it is neither quick […]

On-site Readout of CHips for Infectious Disease Diagnostics (ORCHIDD)

Infectious diseases are a major global challenge. The COVID-19 pandemic demonstrated how even mild pathogens can disrupt society, while antimicrobial resistance continues to rise at an alarming rate. Sepsis, a life-threatening response to infection, is responsible for 1 in 5 deaths worldwide, and this number is growing. These challenges underscore the urgent need for faster […]

Prolispot

Detection of rare dividing cells in blood samples and complex cell mixtures is currently not feasible with existing techniques, which are insufficiently sensitive for biomedical applications. This is critical for applications such as quantifying proliferating cancer and T cells, determining vaccine efficacy, and measuring tumor immune responses or emerging pathogens. Existing methods struggle to detect […]